Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder

Anisman, 2002, Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes, Brain Behav Immun, 16, 544, 10.1016/S0889-1591(02)00011-9 Basterzi, 2005, IL-6 levels decrease with SSRI treatment in patients with major depression, Hum Psychopharmacol Clin Exp, 20, 473, 10.1002/hup.717 Bonaccorso, 2001, Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms, Psychiatry Research, 105, 45, 10.1016/S0165-1781(01)00315-8 Brambilla, 2004, Interleukin-1β and tumor necrosis factor-α in children with major depressive disorder or dysthymia, Journal of Affective Disorders, 78, 273, 10.1016/S0165-0327(02)00315-4 Brustolim, 2006, A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice, International Immunopharmacology, 6, 903, 10.1016/j.intimp.2005.12.007 Capuron, 2004, Cytokines and psychopathology: lessons from Interferon-α, Biol Psychiatry, 56, 819, 10.1016/j.biopsych.2004.02.009 Capuron, 2003, Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment, Biol. Psychiatry, 54, 906, 10.1016/S0006-3223(03)00173-2 Cyranowski, 2007, Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro, Brain, Behaviour, and Immunity, 21, 229, 10.1016/j.bbi.2006.07.005 Diamond, 2006, Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockade, European Neuropsychopharmacology, 16, 481, 10.1016/j.euroneuro.2005.11.011 Himmerich, 2006, Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA Axis, Biol Psychiatry, 60, 882, 10.1016/j.biopsych.2006.03.075 Kaestner, 2005, Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity, Journal of Affective Disorders, 87, 305, 10.1016/j.jad.2005.03.012 Kagaya, 2001, Plasma concentrations of interleukin-1β, interleukin.6, soluble interleukin-2 receptor and tumor necrosis factor α of depressed patients in Japan, Neuropsychobiology, 43, 59, 10.1159/000054867 Kenis, 2002, Effects of antidepressants on the production of cytokines, International Journal of Neuropsychopharmacology, 5, 401, 10.1017/S1461145702003164 Kim, 2007, Cytokine imbalance in the pathophysiology of major depressive disorder, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1044, 10.1016/j.pnpbp.2007.03.004 Kubera, 2004, Stimulatory effect of antidepressant on the production of IL-6, International Immunopharmacology, 4, 185, 10.1016/j.intimp.2003.11.006 Lanquillon, 2000, Cytokine production and treatment response in major depressive disorder, Neuropsychopharmacology, 22, 370, 10.1016/S0893-133X(99)00134-7 Lee, 2006, The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder, International Immunopharmacology, 6, 1298, 10.1016/j.intimp.2006.03.015 Lin, 2000, The in vitro immunosuppressive effects of moclobemide in healthy volunteers, Journal of Affective Disorders, 58, 69, 10.1016/S0165-0327(99)00076-2 Maes, 1995, Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression, Journal of Affective Disorders, 18, 301, 10.1016/0165-0327(95)00028-L Maes, 1997, Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression, Cytokine, 9, 853, 10.1006/cyto.1997.0238 Maes, 1999, Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion, Neuropsychopharmacology, 20, 370, 10.1016/S0893-133X(98)00088-8 Maes, 2002, Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukaemia inhibitory factor receptor, Schizophrenia Research, 54, 191, 10.1016/S0920-9964(00)00094-3 Malek-Ahmadi, 2004, Bupropion for treatment of interferon-induced depression, The Annals of Pharmacotherapy, 38, 1202, 10.1345/aph.1D516 Marques-Deak, 2007, Cytokine profiles in women with different subtypes of major depressive disorder., Journal of Psychiatric Research, 10.1016/j.jpsychires.2005.11.003 Mikova, 2001, Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis, European Neuropsychopharmacology, 11, 203, 10.1016/S0924-977X(01)00081-5 Müller, 2000, Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation, World J Biol Psychiatry, 1, 173, 10.3109/15622970009150588 Myint, 2005, Th1, Th2, and Th3 cytokine alterations in major depression, Journal of Affective Disorders, 88, 167, 10.1016/j.jad.2005.07.008 Narita, 2006, Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 1159, 10.1016/j.pnpbp.2006.03.030 O'Brien, 2006, Cytokine profiles in bipolar affective disorder: focus on acutely ill patients, Journal of Affective Disorders, 90, 263, 10.1016/j.jad.2005.11.015 O'Brien, 2007, Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy, Journal of Psychiatric Research, 41, 326, 10.1016/j.jpsychires.2006.05.013 Pollak, 2003, The EAE-associated behavioural syndrome: I. Temporal correlation with inflammatory mediators, Journal of Neuroimmunology, 137, 94, 10.1016/S0165-5728(03)00075-4 Roumestan, 2007, Anti-inflammatory properties of desipramine and fluoxetine, Respiratory Research, 8, 35, 10.1186/1465-9921-8-35 Schiepers, 2005, Cytokines in major depression, Progress in Neuro-Psychophatmacology & Biological Psychiatry, 29, 201, 10.1016/j.pnpbp.2004.11.003 Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al., in press. Song, 1998, The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression, Journal of Affective Disorders, 49, 211, 10.1016/S0165-0327(98)00025-1 Szuster-Ciesielska, 2003, In vitro immunoregulatory effects of antidepressants in healthy volunteers, Polish Journal of Pharmacology, 55, 353 Tsao, 2006, Cytokines and serotonin transporter in patients with major depression, Progress in Neuro-Psychophatmacology & Biological Psychiatry, 30, 899, 10.1016/j.pnpbp.2006.01.029 Tuglu, 2003, Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder, Psychopharmacology, 170, 429, 10.1007/s00213-003-1566-z